title: Amino acids do not suppress proteolysis in premature neonates.
abstract: To determine whether increased amino acid availability can reduce proteolysis in premature neonates and to assess the capacity of infants born prematurely to acutely increase the irreversible catabolism of the essential amino acids leucine (via oxidation) and phenylalanine (via hydroxylation to form tyrosine), leucine and phenylalanine kinetics were measured under basal conditions and in response to a graded infusion of intravenous amino acids (1.2 and 2.4 g. kg(-1). day(-1)) in clinically stable premature (approximately 32 wk gestation) infants in the 1st wk of life. In contrast to the dose-dependent suppression of proteolysis seen in healthy full-term neonates, the endogenous rates of appearance of leucine and phenylalanine (reflecting proteolysis) were unchanged in response to amino acids (297 +/- 21, 283 +/- 19, and 284 +/- 31 micromol. kg(-1). h(-1) for leucine and 92 +/- 6, 92 +/- 4, and 84 +/- 7 micromol. kg(-1). h(-1) for phenylalanine). Similar to full-term neonates, leucine oxidation (40 +/- 5, 65 +/- 6, and 99 +/- 7 micromol. kg(-1). h(-1)) and phenylalanine hydroxylation (12 +/- 1, 16 +/- 1, and 20 +/- 2 micromol. kg(-1). h(-1)) increased in a stepwise fashion in response to graded amino acids. This capacity to increase phenylalanine hydroxylation may be crucial to meet tyrosine needs when exogenous supply is limited. Finally, to determine whether amino acids stimulate glucose production in premature neonates, glucose rate of appearance was measured during each study period. In response to amino acid infusion, rates of endogenous glucose production were unchanged (and near zero).
authors.affiliation: Section of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, 699 West Dr. RR208, Indianapolis, IN 46202, USA. bpoindex@iupui.edu
authors.forename: B B
authors.initials: BB
authors.lastname: Poindexter
authors.forename: C A
authors.initials: CA
authors.lastname: Karn
authors.forename: C A
authors.initials: CA
authors.lastname: Leitch
authors.forename: E A
authors.initials: EA
authors.lastname: Liechty
authors.forename: S C
authors.initials: SC
authors.lastname: Denne
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage*; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D005865:Gestational Age; D006801:Humans; D006900:Hydroxylation; D007231:Infant, Newborn; D007234:Infant, Premature / Q000378:metabolism*; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood; D007700:Kinetics; D007930:Leucine / Q000097:blood; D008297:Male; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D010649:Phenylalanine / Q000097:blood; D011506:Proteins / Q000378:metabolism*; D014443:Tyrosine / Q000097:blood
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D007328:Insulin; D011506:Proteins; D014443:Tyrosine; D010649:Phenylalanine; D007930:Leucine